Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 057966/0275 | |
| Pages: | 11 |
| | Recorded: | 10/29/2021 | | |
| Attorney Dkt #: | 1441-20000.01 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/24/2023
|
Application #:
|
17465727
|
Filing Dt:
|
09/02/2021
|
|
Publication #:
|
|
Pub Dt:
|
02/24/2022
| | | | |
|
Title:
|
FUSION PROTEIN COMPOSITION(S) COMPRISING MASKED TYPE I INTERFERONS (IFNA AND IFNB) FOR USE IN THE TREATMENT OF CANCER AND METHODS THEREOF
|
|
|
Assignee
|
|
|
|
|
| 258 DENSLOW AVENUE |
| LOS ANGELES, CALIFORNIA 90049 |
|
|
Correspondence name and address
|
| |
SHANE M. POPP
|
| |
3460 BARRY AVENUE
|
| |
ATTN: QWIXEL THERAPEUTICS
|
| |
LOS ANGELES, CA 90066
|
Search Results as of:
05/11/2024 08:36 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
